Related Experiment Video

Updated: Jul 6, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Therapeutic strategies to slow chronic kidney disease progression

Elke Wühl1, Franz Schaefer

  • 1Division of Pediatric Nephrology, University Hospital Heidelberg for Pediatric and Adolescent Medicine, Im Neuenheimer Feld 151, Heidelberg, Germany. elke.wuehl@med.uni-heidelberg.de

Pediatric Nephrology (Berlin, Germany)
|March 13, 2008
PubMed

Insights

Childhood chronic kidney disease progression can be slowed by managing blood pressure and proteinuria. Renin-angiotensin-system antagonists and lifestyle factors are key to preserving kidney function.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Renal Medicine

Background:

  • Childhood chronic kidney disease (CKD) often progresses to end-stage renal failure.
  • Hypertension and proteinuria are primary drivers of CKD progression, irrespective of the initial cause.
  • Effective management is crucial to slow disease advancement.

Purpose of the Study:

  • To review therapeutic strategies for preventing the progression of childhood chronic kidney disease.
  • To highlight the role of blood pressure control and proteinuria reduction.
  • To discuss the impact of other metabolic factors on renal health.

Main Methods:

  • Review of current therapeutic strategies for pediatric CKD.
  • Analysis of the role of renin-angiotensin-system (RAS) antagonists.
  • Examination of multifactorial contributors to CKD progression.

Main Results:

  • Controlling blood pressure, potentially below the 75th percentile, offers renoprotective benefits.
  • RAS antagonists provide renoprotection via blood pressure reduction, antiproteinuric, antifibrotic, and anti-inflammatory effects.
  • Managing dyslipidemia, anemia, and mineral metabolism is vital.

Conclusions:

  • Therapeutic strategies should focus on controlling hypertension and proteinuria to slow CKD progression.
  • Comprehensive management including RAS antagonists and normalization of hemoglobin, lipids, and mineral metabolism is essential for preserving renal function in children.
  • Early and aggressive intervention can significantly alter the course of pediatric CKD.

More Related Videos

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...